Connect with us

Health

Impact Guru Foundation and STCI Finance Ltd Launch Care on Wheels (C.O.W) Program in Mumbai

Published

1 year ago

on

Impact Guru Foundation, an organization that aims to facilitate access to affordable healthcare, has launched its flagship program, Care on Wheels (C.O.W), in Mumbai.

With the generous support of STCI Finance Ltd under its Corporate Social Responsibility (CSR) initiative, the C.O.W program aims to deliver essential healthcare services to the doorsteps of communities in need, transcending barriers of accessibility and affordability. The launch event occurred at Kamgar Kalyan Mandal in Chinchpokli East, symbolizing the commitment to reaching the heart of communities.

The Care on Wheels program is structured to provide primary healthcare, both preventive and curative, to underserved areas, including rural, tribal, slums, and urban regions. The mobile units enable healthcare services to reach the most remote and needy areas, overcoming the challenges of inaccessibility and non-availability.

The key objectives of the Care on Wheels (C.O.W) program are centered around ensuring comprehensive healthcare accessibility to underserved communities. It also aims to enhance awareness within these communities.

Sundeep Talwar, CEO of Impact Guru Foundation, said, “We are thrilled to launch the Care on Wheels program in Mumbai along with STCI Finance Limited, bringing healthcare services to the doorsteps of those who need it the most. This initiative aligns with our mission to create a positive impact on society and improve the overall well-being of communities.”

V Narayanamurthy, MD & CEO of STCI Finance Ltd, commented, “STCI Finance Ltd, is proud to support the Care on Wheels program that will provide last mile healthcare connectivity at the doorstep of the underserved communities. This initiative resonates with our commitment to contribute to community welfare and healthcare accessibility to those in need of medical assistance and thus make a meaningful difference in the lives of the underserved people.”

The launch event saw the presence of Vikas Kaul, Co-Founder, and CPO of ImpactGuru.com, V Narayanamurthy, MD & CEO of STCI Finance Limited, Suparna Sharma, Company Secretary and Chief Compliance Officer and Executives/Staff of STCI Finance Limited, highlighting the collaborative effort and commitment of both organizations towards this transformative healthcare initiative.

Vikas Kaul, who is also a trustee with Impact Guru Foundation said, “I extend my heartfelt appreciation to STCI Finance Ltd for steering the way in bringing about healthcare transformation through the Care on Wheels program. Together, we can drive change and empower communities for a healthier, brighter tomorrow.”

Impact Guru Foundation

Headquartered in Delhi, Impact Guru Foundation (IGF) was established in 2014 with the mission to “provide access to quality and equitable healthcare for the deprived by building efficacies to impact 5 million lives by 2030”. The main aim is to put forward a platform where each individual can easily avail of preventative, curative, and critical care. Since, its inception IGF has executed projects impacting 450,000+ lives on pan India level. IGF has been recognized and awarded by various industry bodies. #HappyBharatHealthyBharat https://www.impactgurufoundation.org/

STCI Finance Ltd

STCI Finance Limited, a Systemically Important- Non Deposit taking Non-Banking Financial Company (NBFC-ND-SI) / Middle layer NBFC (NBFC-ML), has been undertaking lending and financing activities since year 2008. The Company is a diversified mid-market NBFC that provides customized financial solutions to a wide spectrum of customers ranging from Corporate, firms and High Net worth individuals through its loan products offerings of Loan against securities, Corporate Loan-Real Estate and Corporate Loan- Non- Real Estate. The Company operates from its corporate office in Mumbai and representative offices in Delhi, Pune, Hyderabad, Bengaluru, Ahmedabad and Kolkata.

STCI Finance Limited has a qualified and experienced management team headed by V. Narayanamurthy, Managing Director and CEO, who has more than 33 years of experience in the Banking and Financial sector. The Company benefits from the strength of its shareholding majorly comprising of Public Sector Banks as well as from its diversified and professional Board of Directors.

Related Topics:

Health

Groundbreaking Study Reveals Evolutionary Origins of Sleep in Single-Celled Algae

Published

5 hours ago

on

April 3, 2025

By

Cross-Kingdom Conservation of Sleep-Related Genes in Chlamydomonas Sheds Light on Fundamental Biological Process

Mysuru, Karnataka, 3 April 2025 — A groundbreaking study published in the Journal of Cellular Biochemistry has uncovered compelling evidence that sleep, a behavior once thought to be exclusive to complex organisms, may have its roots in the simplest forms of life. The research, led by an international team of scientists, identifies 112 putative sleep-related genes in the single-celled green alga Chlamydomonas reinhardtii, suggesting that the molecular mechanisms regulating sleep have been conserved across kingdoms for over 500 million years.

Key Findings:

  • Evolutionary Conservation: The study reveals that sleep-related genes in humans share significant similarities with those in Chlamydomonas, highlighting an evolutionary continuum from unicellular organisms to mammals.
  • Novel Discoveries: Among the identified genes are previously uncharacterized proteins, such as CHLRE_16g686650v5, which exhibit high sequence similarity to human sleep genes, opening new avenues for understanding sleep regulation.
  • Functional Insights: Well-known proteins like casein kinase I (CKI) and voltage-dependent calcium channels, critical for circadian rhythms and signaling in humans, were also found in Chlamydomonas, reinforcing their pleiotropic functions.

Implications for Science and Medicine:

This research challenges traditional views of sleep as a purely neural phenomenon, proposing instead that its origins lie in fundamental cellular processes. “Our findings suggest that sleep’s essential functions—energy conservation, cellular repair, and adaptation—may have evolved early in life’s history,” said Pandi-Perumal, one of the study’s lead authors. “Our current findings related to putative sleep genes in Chlamydomonas, a flagellated autotrophic plankton, could revolutionize how we view the evolution of human sleep genes, which eventually helps to study sleep disorders and develop potential therapies by targeting conserved pathways.”

Why It Matters:

  • Model Organism: Chlamydomonas, a simple alga with a well-mapped genome, offers a powerful tool for dissecting sleep mechanisms without the complexity of animal models.
  • Future Research: The study paves the way for exploring how these putative sleep genes in single-celled organisms contribute to survival, with potential applications in neurology, chronobiology, and even synthetic biology.

Expert Commentary:

“If sleep orthologs exist in algae, it forces us to rethink its purpose,” noted Dr. Chidambaram, co-corresponding author and a professor at the Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru, Karnataka, India. “This work bridges the gap between microbiology and neuroscience, offering a unified framework to decode sleep’s mysteries through phylogenomics.”

According to Dr. Saravanan, one of the co-authors and Bioinformatics expert, “This study presents an interesting computational framework that enhances cross-genomics comparison by integrating multiple phylogenomic analysis of sleep genes such as Gene ontology, Interpro sites analysis, Repeats analysis and Pathway analysis, offering significant improvements in accuracy, efficiency, and analytical depth.”

According to Prof. Abraham, a Former Professor & Head of the Post-Graduate Department of Botany, at The American College, Madurai, who is one of the co-authors of the study said, “This is an exemplary work, even though we say it ourselves. This phylogenomics study unveils unprecedented insights into evolutionary and functional parallels between putative sleep genes of Chlamydomonas and human sleep genes.”

Overall, the results of this study present an interesting and in-depth analysis of Cross-Kingdom Genomic Conservation of Putative Human Sleep-Related Genes in Chlamydomonas, uncovering previously unreported evolutionary and functional parallels, particularly in protein kinase domains involved in the information storage and processing, providing new insights into conserved genetic elements and their implications in cellular processes.

Publication Details:

The full study, “Cross-Kingdom Genomic Conservation of Putative Human Sleep-Related Genes: Phylogenomic Evidence From Chlamydomonas reinhardtii,” is available in the Journal of Cellular Biochemistry (2025; DOI: [https://doi.org/10.1002/jcb.70030]).

For Media Inquiries:

Contact: Lemuria Global Network
Email: lemuriaglobal@gmail.com

About the Journal of Cellular Biochemistry:

A peer-reviewed publication by Wiley, the journal advances research on cellular mechanisms underpinning health and disease. https://onlinelibrary.wiley.com/doi/full/10.1002/jcb.70030

How to cite this paper:

Pandi-Perumal SR, Saravanan KM, Paul S, Abraham GC, Warren Spence D, Chidambaram SB. Cross-Kingdom Genomic Conservation of Human Sleep-Related Gene Orthologs: Phylogenomic Evidence from Chlamydomonas reinhardtii. J Cellular Biochem. https://doi.org/10.1002/jcb.70030 (First published: 31 March 2025).

Continue Reading

Health

DIZBI Secures Seed Investment, Valued at ₹20 Crores, to Pioneer Traditional Healthcare Digitization

Published

2 weeks ago

on

March 21, 2025

By

Bangalore, India – March 20, 2025 – DIZBI is excited to announce the successful closure of its seed funding round, with a post-money valuation of ₹20 crores. This investment marks a significant endorsement of DIZBI’s innovative approach to healthcare, blending traditional practices with cutting-edge technology.

Founded in 2024 after being acquired by entrepreneur Suresh Dakavarapu from PDS Group, DIZBI launched its operations to revolutionize traditional medicine by creating a holistic, integrated healthcare platform. This platform not only connects practitioners with global audiences but also offers seamless access to e-pharmacies and diagnostic labs, thereby simplifying patient care.

The funds from this round will enable DIZBI to enhance its technological capabilities, expand its reach globally, and strengthen community ties among practitioners and patients. Key initiatives will include:

  • Developing e-labs and expanding e-pharmacy offerings to enhance service delivery.
  • Scaling marketing efforts to educate and engage a broader audience in the benefits of holistic, traditional healthcare.
  • Building a supportive, knowledgeable community that fosters interaction and growth among traditional healthcare providers and patients.
  • Launching our comprehensive platform nationally, showcasing our commitment to integrating traditional healthcare practices with modern technological infrastructure.

Suresh Dakavarapu, CEO of DIZBI, expressed his gratitude: “We are profoundly grateful for the trust our investors, including many from the traditional healthcare community, have placed in us. Their support not only validates our mission but also strengthens our resolve to make traditional healthcare accessible and efficient through technological innovation.”

About DIZBI:

DIZBI is a first-of-its-kind digital platform designed to unify traditional healthcare components — practitioners, clinics, pharmacies, and diagnostic services — under one seamless digital ecosystem. We provide practitioners with state-of-the-art digital tools free of charge, allowing them to focus on what they do best: healing. DIZBI also empowers patients by providing reliable access to a wide range of traditional healthcare services and practitioners, ensuring that every step of their health journey is well-supported.

For further information, media features, or interviews, please contact: Saurab Gupta (CFO DIZBI) @ saurabh.gupta@dizbi.com ; 080-41606335

Continue Reading

Health

Healthcare startup CureAble raised Rs 2 Crore in pre-seed to transform neurodiverse care in India

Published

1 month ago

on

February 19, 2025

By

 CureAble, a Delhi-based Healthcare startup, focusing on personalized therapies for special-needs children, has raised Rs2 crore in a pre-seed round from a US-based investment firm Brahma Tank.

Founded in July 2023 by childhood friends Krishnakant Singh, Arbob Mehmood, Atabik Fasahat, and Vikas Deep, CureAble aims to transform special-needs care for neurodivergent children through a planned, personalized, and trackable approach to their development.

The funds will be used to establish multiple therapy centers and special schools across India while growing their team. The roadmap also includes accelerating the development of specialized therapeutic tools and technologies, alongside community outreach initiatives. Founder Krishnakant Singh emphasizes that “These steps will transform the special needs care sector, bringing innovation and empathy to therapy-based services while revolutionizing how special-needs therapies are provided.”

Founder Vikas Deep, who also has more than 12 years of experience in special-needs therapy, says, “Every child is unique, yet therapy is often treated as a one-size-fits-all solution, leaving many without real progress. At CureAble, we take a deeply personal approach–understanding each child’s strengths, challenges, and needs–to provide therapy that truly works. Seeing children grow and connect in ways their families once feared impossible is what drives us every day,”

“Post-COVID, there’s been a sharp rise in learning disabilities and ADHD among children, driven by excessive screen time, reduced socialization, and fast-paced curriculum. Parental neglect, denial, and busy lifestyles have further fueled these challenges. Existing systems can’t support them. We need a personalized, transparent, and trackable framework to ensure consistent care during their crucial growth years.” says Founder Atabik Fasahat.

About the future of CureAble, Founder Arbob Mehmood says, “Our vision extends beyond India. In the next 5 years, we aim to impact 100 million special-needs children globally through a combination of home-based care, therapy centers, school-based programs, and technology-driven solutions like VR and app-based therapies.”

“CureAble is tackling one of the most pressing yet overlooked challenges in healthcare–ensuring that neurodivergent children receive the right support at the right time. Their data-driven and deeply personalized approach to therapy has the potential to revolutionize how therapy is delivered globally. What impressed me most is their deep commitment to both scalability and impact, ensuring that quality special-needs care is accessible across India and beyond. This investment aligns perfectly with my commitment to supporting ventures that drive social impact alongside sustainable growth.” – Gurmeet Likhari, Founder – Brahma Tank

In India, 1 in 8 children grapples with some kind of neurodivergent conditions, including millions of children with autism, ADHD, mental retardation, Down syndrome, slow learners and other developmental challenges. Shockingly, up to 80% of these children do not receive the necessary care. Globally, with over 1.2 billion people with such conditions, with global market size expected to reach USD 68.6 billion by 2028. These statistics highlight a dire need for improved special-needs care systems across the world, which CureAble, through its innovative framework, is well positioned for significant growth.

Continue Reading

Health

Evoke Hair & Skin Clinic: The Best Hair Transplant Clinic in Delhi & Gurgaon for Natural and Permanent Hair Restoration

Published

2 months ago

on

February 17, 2025

By

Today, hair loss is more than a cosmetic issue. The main reason is that it directly impacts your self-esteem, confidence, personality, and overall well-being. Whether it’s genetic baldness, stress-induced hair fall, or medical conditions, the demand for the best and permanent hair restoration is continuously increasing. For those searching for the best hair transplant clinic in Delhi or Gurgaon, Evoke Hair & Skin Clinic stands out as a trustworthy place for all types of hair and skin treatments at affordable prices.

With an expert team of hair specialists in Delhi, they leverage advanced technologies while providing services that ensure a high success rate. Evoke Hair & Skin Clinic has transformed the lives of thousands of individuals by offering exceptional services. From FUE hair transplants to PRP therapy and scalp rejuvenation, the clinic has won the hearts of several people. Those who are looking for holistic hair restoration solutions can reach out to them without any second thoughts.

Why Evoke Hair & Skin Clinic Stands Out?

You need to choose the right hair transplant clinic in Delhi NCR to achieve long-lasting and natural results within a limited time. Evoke Hair & Skin Clinic is well-renowned for its excellence in hair restoration. Moreover, the clinic has a team of experienced Hair Specialists & Dermatologists. That’s why, the clinic is home to some of the most skilled dermatologists in Delhi for hair. The industry experts ensure precision and safety.

The team utilizes advanced hair transplant techniques such as FUE (Follicular Unit Extraction) and DHT (Direct Hair Transplantation) along with cutting-edge GFC (Growth Factor Concentrate) treatment. It is also one of the best non-surgical procedures to promote hair growth by stimulating the hair follicles. They guarantee all their patients natural-looking, minimally invasive, and highly effective transplants and treatments.

At Evoke Hair & Skin Clinic, experts understand that every patient’s hair loss pattern is unique. Keeping note of this, they provide customized treatment plans to suit individual needs. Patients can freely discuss their doubts with experts without any hesitation. Also, with the latest technology and a patient-centric approach, the clinic ensures a seamless and comfortable experience.

They have a proven track record of thousands of satisfied patients with successful hair transplants. Expert doctors boost their confidence and transform their appearance to a great extent.

PRP Therapy: A Non-Surgical Hair Regrowth Solution

Even if you are not ready for a transplant, PRP therapy (Platelet-Rich Plasma) is a revolutionary non-surgical treatment available at Evoke Hair & Skin Clinic. Using the patient’s platelets, PRP therapy stimulates hair follicles. The treatment is done to improve hair thickness and reduce hair fall. It is undoubtedly a highly effective treatment for early-stage hair loss, post-transplant recovery, and overall scalp health.

So, if you’re looking for PRP in Delhi or PRP in Gurgaon, Evoke Hair & Skin Clinic is the go-to choice for safe and effective PRP treatments. You can book your services at your fingertips.

Best Hair Transplant Clinic in Gurgaon & Delhi NCR: Trusted by Thousands

Evoke Hair & Skin Clinic is not just another hair and skin clinic in Delhi; it is a trusted name in hair restoration. Expert doctors at Evoke have over 15+ years of experience in providing exceptional results and high patient satisfaction. They provide services that extend beyond Delhi. Thus, their team caters to patients looking for the best hair transplant clinic in Gurgaon as well.

With a patient-first approach, the clinic ensures a stress-free experience. They keep guiding individuals through consultation, treatment, and post-procedure care. Moreover, Evoke Hair & Skin Clinic believes in transparent pricing and ensures affordable, high-quality treatments without compromising on results.

What Patients Say About Evoke Hair & Skin Clinic?

1. “I was struggling with severe hair loss and bald patches. After consulting Evoke Hair & Skin Clinic, I opted for the FUE hair transplant. During the treatment, I was quite nervous. But to my surprise, the results have been life-changing! Let me tell you that the entire process was smooth, and the team was extremely supportive.” – Rohit S., New Delhi

2. “For the past few years, I had tried everything for my thinning hair–oils, medications, PRP treatments, and whatnot. But nothing worked at all! That’s when I decided to visit Evoke. Their dermatologist in Delhi for hair suggested a customized transplant plan. And yes, within a few weeks, the results are incredible, and I finally feel confident again!” Thanks to the experts at Evoke!- Ankit M., Gurgaon

3. “Evoke Hair & Skin Clinic is hands down the best hair transplant clinic in Delhi NCR. They use the latest technology, and the team is highly professional. I would highly recommend that you avail yourself of their services. My DHT transplant results look completely natural.” – Varun T., Delhi NCR

Book Your Consultation Today!

If hair loss is affecting your confidence or self-esteem, don’t wait! Evoke Hair & Skin Clinic offers the best hair transplant solutions tailored to your specific needs. So, whether you are looking for PRP therapy, FUE or DHT hair transplant, you can contact their team and they will guide you through the journey of regaining your hair–and your confidence.

Visit Evoke Hair & Skin Clinic in Delhi & Gurgaon Now!

Website: https://www.evokeclinic.co/

Email: contact@evokehair.com

Continue Reading

Health

Tula Hospital has received significant investment from Dr. Amit Mann

Published

2 months ago

on

February 7, 2025

By

Tula Hospitals, a leader in providing advanced healthcare services to the community in Palwal region, is excited to announce that Dr. Amit Mann, a renowned nephrologist, entrepreneur, and Director-Mann Multispeicality Hospital Rohtak, has made a significant investment in the hospital. This strategic partnership aims to further enhance Tula Hospital’s commitment to delivering exceptional medical care and state-of-the-art healthcare services to its patients.

Dr. Amit Mann, who has a distinguished track record in both healthcare and business, is investing in Tula Hospital as part of the hospital’s ongoing efforts to expand its reach, incorporate cutting-edge technologies, and continuously improve the quality of its services. His wealth of expertise in the medical field and his innovative vision for the future of healthcare will serve as an invaluable asset to the institution.

“We are thrilled to have Dr. Amit Mann join the Tula Hospital family,” said Mr. Manish Madhukar, CEO of Tula Hospitals. “His deep understanding of healthcare innovation and his entrepreneurial spirit will bring fresh perspectives to our operations. This investment is a clear testament to the trust and confidence in our mission to provide compassionate, accessible, and world-class medical care to our patients.”

Dr. Amit Mann’s involvement in the hospital will not only contribute to enhancing patient care but also to expanding Tula Hospital’s capacity and outreach, ensuring that the latest medical technologies and treatments are readily available to those who need them most.

“I have long admired the work that Tula Hospital has been doing to improve healthcare access and quality,” said Dr. Amit Mann. “I am excited about the opportunity to contribute to their growth and support the hospital’s goal of advancing patient care through innovative practices. This partnership is a step towards strengthening the healthcare infrastructure in our community.”

As Tula Hospital continues to grow and evolve, Dr. Amit Mann’s investment is poised to accelerate the hospital’s journey toward becoming a leading healthcare provider in the region. His involvement underscores Tula Hospital’s commitment to excellence and its dedication to meeting the needs of its patients with the highest standards of care.

About Tula Hospital:

Tula Hospital, located in Palwal, Haryana, is a 120-bedded superspeciality facility situated on NH-2, Delhi-Mathura Road. Established by Bothanzi Medicals Pvt. Ltd., the hospital offers a comprehensive range of medical services under one roof.

The hospital has achieved significate milestones in just second year of its operations including but not limited to NABH accreditation, ECHS, and Haryana Government Empanelment.

The Hospital is already empanelled with all major health insurance companies and TPA.

The hospital is preferred choice for PSUs like NHAI.

The financial of the hospital is extremely appealing with achieving 29% positive EBIDTA in just second year of its operation.

Specialties and Services:

Tula Hospital provides a variety of medical specialties, such as:

* General Medicine

* General and Laparoscopic Surgery

* Orthopedics and Joint Replacement

* Obstetrics and Gynecology

* Pediatrics and Neonatology

* Dental Services

* Urology

* Anesthesia and Pain Medicine

The hospital also plans to introduce additional specialties, including Cardiology, Gastroenterology, ENT, Neurosurgery, Neurology, Nephrology, Medical Oncology, and Surgical Oncology.

Facilities:

* 24×7 Emergency Services

* Pharmacy

* Laboratory Services

* CT Scan

* Ultrasound and Color Doppler

* X-Ray

* Physiotherapy

* Ambulance Services

* Blood Bank (outsourced)

* Patient Dietetics and Nutrition

Management and Vision:

The hospital is managed by a team of experienced professionals, including:

* Manish Madhulkar (CEO)

* Dr. Virat Veer Yadav (Medical Director)

* Rohit Singh (DGM-Finance)

* Ishwar Singh (Administrator)

* Rakesh Chadra (Head-HR)

* Sunny Dalal (Head-Billing)

* Alok Rawat (Operation Manager)

* Vanda Singh (Head-Customer Care)

The hospital’s mission is to deliver a high standard hospital experience by offering the best, most transparent and most affordable healthcare services. Its vision is to be a leading provider of high-quality affordable healthcare services available for all by creating a network of super-speciality healthcare establishments.

Tula Hospital is committed to providing quality healthcare services to the community, with plans to expand its network to other tier II and tier III cities in northern India

Dr. Amit Mann is a distinguished nephrologist based in Rohtak, Haryana, with over 25 years of experience in kidney care. He currently serves as the Director of Nephrology and Senior Consultant at Mann MultiSpecialty Hospital, located in Company Bagh, Rohtak.

Educational Background and Training:

Dr. Mann completed his MBBS from Pt. B.D.S., P.G.I.M.S., Rohtak, in 2000. He pursued his MD in Internal Medicine at Army Hospital R & R, Delhi University, graduating in 2006. Further specializing in nephrology, he obtained his DM in Nephrology from Sri Ramachandra University and Research Institute, Chennai, in 2010.

Professional Experience:

From 2012 to 2019, Dr. Mann served as the Associate Professor and Head of the Department of Nephrology at Pt. B.D.S., P.G.I.M.S., Rohtak. During this tenure, he managed over a lakh of kidney patients and performed more than two lakhs of dialysis procedures. He was also part of the team that conducted India’s first HIV-positive kidney transplant at Shri Ramachandra Medical College & Hospital in Chennai.

Clinical Expertise:

Dr. Mann’s areas of expertise include:

* Hemodialysis

* Continuous Ambulatory Peritoneal Dialysis (CAPD)

* Acute Peritoneal Dialysis

* Kidney Transplantation (both live and cadaveric)

* Kidney Biopsy and other nephrological interventions

For media inquiries, please contact:

Mr. Rakesh Chandra

Tula Hospital

Email: hrhead@tulahospitals.com

Website: www.tulahospitals.com

Continue Reading

Trending